mr stockboy, So my take is the new BOD is digging into the company starting with the financials and where they can cut costs. Once they figure out the cost cutting aspect they'll start by booting out the unneeded personnel. I think we're looking at 2024 before there will be a serious "for sale" sign or partnership in the works. Wouldn't it be nice to start an advertising campaign and take Vascepa out of the closet before the patents expire. Time is not our friend.
News 
Market Data 
Discover 
